Title : Neonatal Persistent Exposure to 6-Propyl-2-thiouracil, a Thyroid-Disrupting Chemical, Differentially Modulates Expression of Hepatic Catalase and C/EBP-β in Adult Rats.

Pub. Date : 2016 Feb

PMID : 26459835






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Neonatal Persistent Exposure to 6-Propyl-2-thiouracil, a Thyroid-Disrupting Chemical, Differentially Modulates Expression of Hepatic Catalase and C/EBP-beta in Adult Rats. Propylthiouracil CCAAT/enhancer binding protein beta Rattus norvegicus
2 Persistent exposure of rats to 6-propyl-2-thiouracil (PTU) from birth resulted in decreases in plasma thyroid hormone (TH) levels and hepatic expression of catalase and CCAAT enhancer binding protein beta (C/EBP-beta). Propylthiouracil CCAAT/enhancer binding protein beta Rattus norvegicus
3 Persistent exposure of rats to 6-propyl-2-thiouracil (PTU) from birth resulted in decreases in plasma thyroid hormone (TH) levels and hepatic expression of catalase and CCAAT enhancer binding protein beta (C/EBP-beta). Propylthiouracil CCAAT/enhancer binding protein beta Rattus norvegicus
4 Persistent exposure of rats to 6-propyl-2-thiouracil (PTU) from birth resulted in decreases in plasma thyroid hormone (TH) levels and hepatic expression of catalase and CCAAT enhancer binding protein beta (C/EBP-beta). Propylthiouracil CCAAT/enhancer binding protein beta Rattus norvegicus
5 Persistent exposure of rats to 6-propyl-2-thiouracil (PTU) from birth resulted in decreases in plasma thyroid hormone (TH) levels and hepatic expression of catalase and CCAAT enhancer binding protein beta (C/EBP-beta). Propylthiouracil CCAAT/enhancer binding protein beta Rattus norvegicus
6 PTU withdrawal on 30 days of birth restored TH levels and C/EBP-beta to control rats in adulthood. Propylthiouracil CCAAT/enhancer binding protein beta Rattus norvegicus